BusinessCancer Genetics, Inc. Announces Strong Fourth Quarter and Full-Year 2015 Results and Provides 2016 Business UpdateBy Nasdaq OMXMar 10, 2016, 8:53 PM UTC
BusinessRedHill Biopharma Announces Peer-Reviewed Publication Demonstrating Therapeutic Potential of YELIVA™ in Cholangiocarcinoma CancerBy Nasdaq OMXMar 10, 2016, 2:03 PM UTC
BusinessOrganovo and Its Customers Present Data Supporting 3D Bioprinted Liver Tissues for Drug Toxicity Testing and Liver Fibrosis ModelingBy Nasdaq OMXMar 10, 2016, 1:05 PM UTC
BusinessVericel Announces Positive Top-Line Results From Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T in Patients With Heart Failure Due to Ischemic Dilated CardiomyopathyBy Nasdaq OMXMar 10, 2016, 1:00 PM UTC
BusinessFibrocell Reports Fourth Quarter and Full Year 2015 Financial Results and Operational HighlightsBy Nasdaq OMXMar 10, 2016, 1:00 PM UTC
BusinessChromaDex Initiates Second Human Clinical Study on NIAGEN® -The World’s First and Only Commercially Available Form of Nicotinamide Riboside (NR)By Nasdaq OMXMar 10, 2016, 11:30 AM UTC
BusinessUmecrine Cognition raises new funds to support clinical development of novel drug candidate GR3027 for hepatic encephalopathy - Phase I clinical trial initiatedBy Nasdaq OMXMar 10, 2016, 7:05 AM UTC
